N., Song, Y., Chen, W., Wang, G., Edden, R
An active-comparator new-user cohort design is less susceptible to healthy user bias and confounding by indication, because an active treatment with similar indication rather than non-users is the comparator [31, 32]
Some are better suited for muscle repair, while others reduce inflammation
Higher levels of these inflammatory cytokines have been found in CSF and serum of patients with ALS and correlate negatively with survival, specifically TNF-alpha, interleukin-10 and interleukin-1 beta [236]
Risk of bias was assessed using an adapted Quality Assessment Tool for In Vitro Studies (QUIN) tool